The Impact of Metrifonate Therapy on Caregivers of Patients with Alzheimer's Disease: Results from the MALT Clinical Trial

OBJECTIVE: To assess the impact on burden reported by caregivers of patients with mild to moderate Alzheimer's disease (AD) who were treated with metrifonate during a randomized double blind clinical trial. DESIGN: Randomized clinical trial, with a 2‐week screening period and a 26‐week double b...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Geriatrics Society (JAGS) 2000-03, Vol.48 (3), p.268-274
Hauptverfasser:	Shikiar, Richard, Shakespeare, Annabelle, Sagnier, Pierre-Philippe, Wilkinson, David, McKeith, Ian, Dartigues, Jean-François, MD, Bruno Dubois
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer's disease Biological and medical sciences caregiver burden Caregivers Carers Clinical trials Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Drug therapy Drugs Elderly people Geriatrics Medical sciences metrifonate Neurology Neuropharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology randomized placebo-controlled trial Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!